Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Alzheimer’s Disease Treatment Market Report 2024

Alzheimer’s Disease Treatment Global Market Report 2025 – By Drug Class (Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins), By Drug Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists), By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics) – Market Size, Trends, And Global Forecast 2025-2034

Alzheimer’s Disease Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Alzheimer’s Disease Treatment Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Alzheimer’s Disease Treatment Market Definition

Alzheimer’s disease treatment refers to a medication designed and developed to treat Alzheimer's. This treatment, which targets the protein beta-amyloid and is an immunotherapy, aids in the reduction of amyloid plaques, which are brain lesions connected to Alzheimer's disease. The progression of this disease causes severe memory impairment, and the person may lose the ability to carry out everyday tasks.

The main types of drugs in Alzheimer’s disease treatment are cholinesterase inhibitors and NMDA receptor antagonists. Cholinesterase inhibitors (also known as acetylcholinesterase inhibitors) are a class of drugs that prevent acetylcholine from being broken down normally. The different drug classes include Cholinergic, memantine, combined drug, AChE inhibitors, and immunoglobulins and involve various therapeutics such as cholinesterase inhibitors, NMDA receptor antagonists, and other therapeutics.

Alzheimer’s Disease Treatment Market Segmentation

The alzheimer’s disease treatment market covered in this report is segmented –

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins

2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists

3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

Subsegments:

1) By Cholinergic: Donepezil, Galantamine, Rivastigmine

2) By Memantine: Memantine Hydrochloride, Extended-Release Memantine

3) By Combined Drug: Donepezil and Memantine Combination

4) By AChE Inhibitors: Tacrine, Physical Inhibitors

5) By Immunoglobulins: IVIG (Intravenous Immunoglobulin), Monoclonal Antibodies

Alzheimer’s Disease Treatment Market Size and growth rate 2025 to 2029: Graph

Alzheimer’s Disease Treatment Market Size 2025 And Growth Rate

The alzheimer’s disease treatment market size has grown strongly in recent years. It will grow from $5.93 billion in 2024 to $6.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to advancements in research and understanding, drug approvals and market entry, government initiatives and funding, public awareness and education.

Alzheimer’s Disease Treatment Market Growth Forecast

The alzheimer’s disease treatment market size is expected to see strong growth in the next few years. It will grow to $8.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine approaches, rising healthcare expenditure, global burden of disease, genetic and biomarker research, emerging markets. Major trends in the forecast period include biotechnological breakthroughs, technological innovations, digital health technologies, precision medicine approaches, neuroinflammation modulation, collaborations and partnerships.

Book your 30 minutes free consultation with our research experts

Contact Us

Alzheimer’s Disease Treatment Market Driver: Rising Prevalence Of Alzheimer's Disease Fuels Growth In The Alzheimer's Disease Treatment Market

The increasing cases of Alzheimer's are a major factor contributing to the growth of the Alzheimer’s disease treatment market. Alzheimer's is the most common type of dementia. The USA Alzheimer's Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s patients by 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s are expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of Alzheimer’s disease is expected to drive the demand of the growth of global Alzheimer’s disease treatment market.

Alzheimer’s Disease Treatment Market Driver: Government Initiatives Fueling Growth In The Alzheimer's Disease Treatment Market

Government initiatives are expected to propel the growth of the Alzheimer's disease treatment market. A government initiative is a plan or action taken by a government to address a specific problem or issue that can be funded by various sources, including taxes, grants, and donations. Government initiatives are used in Alzheimer's disease treatment to research projects, including clinical trials of new drugs and treatments. For instance, in March 2022, the National Institutes of Health (NIH), a US-based primary agency for biomedical and public health research, spending on Alzheimer's and dementia research funding increased by $289 million to reach $3.5 billion. Therefore, government initiatives drive the growth of the Alzheimer's disease treatment market.

Global Alzheimer’s Disease Treatment Market Major Players

Major companies operating in the alzheimer’s disease treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc.

Global Alzheimer’s Disease Treatment Market Trend: I Strategic Focus On Regulatory Approvals In The Alzheimer's Disease Treatment Market

Major companies operating in the Alzheimer's disease treatment market are focusing on regulatory approvals to gain a competitive edge and enhance their product offerings. Regulatory approvals refer to the formal authorization granted by government agencies, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), for a product to be marketed and sold to the public. For instance, in July 2024, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for its Alzheimer's treatment, Kisunla (donanemab-azbt), which is indicated for adults with early symptomatic Alzheimer's disease, including those with mild cognitive impairment and mild dementia. The drug is administered via monthly intravenous infusion and has demonstrated efficacy in slowing the progression of the disease in clinical trials. The approval reflects its potential impact, having received Fast Track, Priority Review, and Breakthrough Therapy designations.

Global Alzheimer’s Disease Treatment Market Trend: Innovative Products In Alzheimer's Disease Treatment Market

Major companies operating in the Alzheimer's disease treatment market are focusing on developing innovative products, such as assay kits, to provide reliable services to customers. An assay kit is a set of reagents and materials used to perform a specific analytical test designed to measure a specific analyte. For instance, in June 2023, Sysmex Corporation, a Japan-based healthcare company, launched the HISCL ß-Amyloid 1-42 Assay Kit and the HISCL ß-Amyloid 1-40 Assay Kit. The products measure Aß levels in the blood using the company's Automated Immunoassay System HISCL-5000/HISCL-800, which aids in the identification of Aß accumulation in the brain, a hallmark of Alzheimer's disease. Patients who have suspected brain Aß accumulation benefit from the Products in terms of less financial, emotional, and physical load.

Alzheimer’s Disease Treatment Market Merger And Acquisition: Lantheus Holdings Inc. Acquires Cerveau Technologies, Inc. To Expand Alzheimer's Disease Imaging Portfolio

In February 2023, Lantheus Holdings Inc., a US-based provider of innovative diagnostic imaging agents and products, acquired Cerveau Technologies, Inc. for an undisclosed amount. Through this acquisition, Lantheus is expected to expand it imaging portfolio into the Alzheimer’s disease. Cerveau Technologies Inc. is a US-based provider of information and technology to researchers and clinicians.

Regional Outlook For The Global Alzheimer’s Disease Treatment Market

North America is the largest region in the Alzheimer’s disease treatment market in 2024. Middle East is expected to be the fastest growing region in the Alzheimer’s disease treatment market share during the forecast period. The regions covered in the Alzheimer’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Alzheimer’s disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Alzheimer’s Disease Treatment Market?

The Alzheimer’s disease treatment market includes revenues earned by entities by temporarily improve symptoms of memory loss and problems with thinking and reasoning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Alzheimer’s Disease Treatment Industry?

The Alzheimer’s disease treatment market research report is one of a series of new reports from The Business Research Company that provides Alzheimer’s disease treatment market statistics, including Alzheimer’s disease treatment industry global market size, regional shares, competitors with an Alzheimer’s disease treatment market share, detailed Alzheimer’s disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Alzheimer’s disease treatment industry. This Alzheimer’s disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Alzheimer’s Disease Treatment Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $6.41 billion
Revenue Forecast In 2034 $8.35 billion
Growth Rate CAGR of 6.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics Subsegments: 1) By Cholinergic: Donepezil, Galantamine, Rivastigmine
2) By Memantine: Memantine Hydrochloride, Extended-Release Memantine
3) By Combined Drug: Donepezil and Memantine Combination
4) By AChE Inhibitors: Tacrine, Physical Inhibitors
5) By Immunoglobulins: IVIG (Intravenous Immunoglobulin), Monoclonal Antibodies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Alzheimer’s Disease Treatment Market Characteristics

    3. Alzheimer’s Disease Treatment Market Trends And Strategies

    4. Alzheimer’s Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Alzheimer’s Disease Treatment Growth Analysis And Strategic Analysis Framework

    5.1. Global Alzheimer’s Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Alzheimer’s Disease Treatment Market Growth Rate Analysis

    5.4. Global Alzheimer’s Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Alzheimer’s Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Alzheimer’s Disease Treatment Total Addressable Market (TAM)

    6. Alzheimer’s Disease Treatment Market Segmentation

    6.1. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cholinergic

    Memantine

    Combined Drug

    AChE inhibitors

    Immunoglobulins

    6.2. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    6.3. Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    Other Therapeutics

    6.4. Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Cholinergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Donepezil

    Galantamine

    Rivastigmine

    6.5. Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Memantine Hydrochloride

    Extended-Release Memantine

    6.6. Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Combined Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Donepezil and Memantine Combination

    6.7. Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of AChE Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tacrine

    Physical Inhibitors

    6.8. Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    IVIG (Intravenous Immunoglobulin)

    Monoclonal Antibodies

    7. Alzheimer’s Disease Treatment Market Regional And Country Analysis

    7.1. Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Alzheimer’s Disease Treatment Market

    8.1. Asia-Pacific Alzheimer’s Disease Treatment Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Alzheimer’s Disease Treatment Market

    9.1. China Alzheimer’s Disease Treatment Market Overview

    9.2. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Alzheimer’s Disease Treatment Market

    10.1. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Alzheimer’s Disease Treatment Market

    11.1. Japan Alzheimer’s Disease Treatment Market Overview

    11.2. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Alzheimer’s Disease Treatment Market

    12.1. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Alzheimer’s Disease Treatment Market

    13.1. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Alzheimer’s Disease Treatment Market

    14.1. South Korea Alzheimer’s Disease Treatment Market Overview

    14.2. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Alzheimer’s Disease Treatment Market

    15.1. Western Europe Alzheimer’s Disease Treatment Market Overview

    15.2. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Alzheimer’s Disease Treatment Market

    16.1. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Alzheimer’s Disease Treatment Market

    17.1. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Alzheimer’s Disease Treatment Market

    18.1. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Alzheimer’s Disease Treatment Market

    19.1. Italy Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Alzheimer’s Disease Treatment Market

    20.1. Spain Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Alzheimer’s Disease Treatment Market

    21.1. Eastern Europe Alzheimer’s Disease Treatment Market Overview

    21.2. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Alzheimer’s Disease Treatment Market

    22.1. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Alzheimer’s Disease Treatment Market

    23.1. North America Alzheimer’s Disease Treatment Market Overview

    23.2. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Alzheimer’s Disease Treatment Market

    24.1. USA Alzheimer’s Disease Treatment Market Overview

    24.2. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Alzheimer’s Disease Treatment Market

    25.1. Canada Alzheimer’s Disease Treatment Market Overview

    25.2. Canada Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Alzheimer’s Disease Treatment Market

    26.1. South America Alzheimer’s Disease Treatment Market Overview

    26.2. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Alzheimer’s Disease Treatment Market

    27.1. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Alzheimer’s Disease Treatment Market

    28.1. Middle East Alzheimer’s Disease Treatment Market Overview

    28.2. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Alzheimer’s Disease Treatment Market

    29.1. Africa Alzheimer’s Disease Treatment Market Overview

    29.2. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Alzheimer’s Disease Treatment Market Competitive Landscape And Company Profiles

    30.1. Alzheimer’s Disease Treatment Market Competitive Landscape

    30.2. Alzheimer’s Disease Treatment Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Alzheimer’s Disease Treatment Market Other Major And Innovative Companies

    31.1. Bristol-Myers Squibb Company

    31.2. AstraZeneca plc

    31.3. Merck Sharp & Dohme Corp.

    31.4. Takeda Pharmaceutical Company Limited

    31.5. Eli Lilly and Company

    31.6. Amgen Inc.

    31.7. Teva Pharmaceutical Industries Ltd.

    31.8. Biogen Inc.

    31.9. UCB S.A.

    31.10. Eisai Co. Ltd.

    31.11. Forest Laboratories LLC

    31.12. Ono Pharmaceutical Co. Ltd.

    31.13. H. Lundbeck A/S

    31.14. Allergan plc

    31.15. Luye Pharma Group

    32. Global Alzheimer’s Disease Treatment Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market

    34. Recent Developments In The Alzheimer’s Disease Treatment Market

    35. Alzheimer’s Disease Treatment Market High Potential Countries, Segments and Strategies

    35.1 Alzheimer’s Disease Treatment Market In 2029 - Countries Offering Most New Opportunities

    35.2 Alzheimer’s Disease Treatment Market In 2029 - Segments Offering Most New Opportunities

    35.3 Alzheimer’s Disease Treatment Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Cholinergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Combined Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of AChE Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: AbbVie Inc. Financial Performance
  • Table 82: Bayer AG Financial Performance
  • Table 83: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Cholinergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Combined Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of AChE Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Alzheimer’s Disease Treatment Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: AbbVie Inc. Financial Performance
  • Figure 82: Bayer AG Financial Performance
  • Figure 83: Novartis AG Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pharmaceutical drugs and biologics logistics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the acne drugs market research report 2022 with industry size, share, segments and market growth

Read More

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Neurodegenerative Disorder Therapeutics Global Market Report 2025 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Alzheimer’s Disease Treatment Global Market Report 2025 – By Drug Class (Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins), By Drug Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists), By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medical Foods Global Market Report 2025 – By Type (Pills, Powder, Other Types), By Application (Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Other Applications), By Sales Channel (Retail Sales, Online Sales, Institutional Sales) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Genetic Testing Global Market Report 2025 – By Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications), By End User (Hospitals And Clinics, Diagnostic Laboratories And Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inflammatory Bowel Disease Treatment Global Market Report 2025 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Alzheimer’s Disease Treatment market?

Alzheimer’s disease treatment refers to a medication designed and developed to treat Alzheimer's. This treatment, which targets the protein beta-amyloid and is an immunotherapy, aids in the reduction of amyloid plaques, which are brain lesions connected to Alzheimer's disease. The progression of this disease causes severe memory impairment, and the person may lose the ability to carry out everyday tasks. For further insights on the Alzheimer’s Disease Treatment market, request a sample here

How will the Alzheimer’s Disease Treatment market drivers and restraints affect the market dynamics? What forces will shape the Alzheimer’s Disease Treatment industry going forward?

The Alzheimer’s Disease Treatment market major growth driver - Government Initiatives Fueling Growth In The Alzheimer's Disease Treatment Market. For further insights on the Alzheimer’s Disease Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Alzheimer’s Disease Treatment market?

The Alzheimer’s Disease Treatment market size has grown strongly in recent years. The alzheimer’s disease treatment market size has grown strongly in recent years. It will grow from $5.93 billion in 2024 to $6.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to advancements in research and understanding, drug approvals and market entry, government initiatives and funding, public awareness and education. The alzheimer’s disease treatment market size is expected to see strong growth in the next few years. It will grow to $8.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine approaches, rising healthcare expenditure, global burden of disease, genetic and biomarker research, emerging markets. Major trends in the forecast period include biotechnological breakthroughs, technological innovations, digital health technologies, precision medicine approaches, neuroinflammation modulation, collaborations and partnerships. For further insights on the Alzheimer’s Disease Treatment market, request a sample here

How is the Alzheimer’s Disease Treatment market segmented?

The alzheimer’s disease treatment market covered in this report is segmented –
1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics
Subsegments:
1) By Cholinergic: Donepezil, Galantamine, Rivastigmine
2) By Memantine: Memantine Hydrochloride, Extended-Release Memantine
3) By Combined Drug: Donepezil and Memantine Combination
4) By AChE Inhibitors: Tacrine, Physical Inhibitors
5) By Immunoglobulins: IVIG (Intravenous Immunoglobulin), Monoclonal Antibodies For further insights on the Alzheimer’s Disease Treatment market, request a sample here

Which region has the largest share of the Alzheimer’s Disease Treatment market? What are the other regions covered in the report?

North America is the largest region in the Alzheimer’s disease treatment market in 2024. Middle East is expected to be the fastest growing region in the Alzheimer’s disease treatment market share during the forecast period. The regions covered in the Alzheimer’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Alzheimer’s Disease Treatment market, request a sample here.

Who are the major players in the Alzheimer’s Disease Treatment market?

Major companies operating in the alzheimer’s disease treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc. . For further insights on the Alzheimer’s Disease Treatment market, request a sample here.

What are the key trends in the Alzheimer’s Disease Treatment market?

Major trends in the Alzheimer’s Disease Treatment market include Innovative Products In Alzheimer's Disease Treatment Market. For further insights on the Alzheimer’s Disease Treatment market, request a sample here.

What are the major opportunities in the Alzheimer’s Disease Treatment market? What are the strategies for the Alzheimer’s Disease Treatment market?

For detailed insights on the major opportunities and strategies in the Alzheimer’s Disease Treatment market, request a sample here.

How does the Alzheimer’s Disease Treatment market relate to the overall economy and other similar markets?

For detailed insights on Alzheimer’s Disease Treatment's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Alzheimer’s Disease Treatment industry?

For detailed insights on the mergers and acquisitions in the Alzheimer’s Disease Treatment industry, request a sample here.

What are the key dynamics influencing the Alzheimer’s Disease Treatment market growth? SWOT analysis of the Alzheimer’s Disease Treatment market.

For detailed insights on the key dynamics influencing the Alzheimer’s Disease Treatment market growth and SWOT analysis of the Alzheimer’s Disease Treatment industry, request a sample here.